View All Questions

Semaine trois, même dose : l'anxiété est retombée sous mon niveau de base — parce que le chaos qui l'alimentait a diminué. Les deux premières semaines, mon corps confondait « stimulé » et « en danger ». Ça s'est calibré. Tiens le journal de bord que ta prescriptrice suggère, la tendance compte plus que les pics.

Counter-experience so you have both: I tried Foquest for three months and went back. The difference for me was maybe 90 minutes, not the advertised gap, and the cost delta didn't survive that math. Individual duration variance on these is huge — ask your doctor about a trial month before committing the budget.

The rough-mornings plot twist matches my quit attempt exactly — turns out 'pre-dose caffeine bridge' was a real load-bearing part of my routine. Landed on the same one-cup treaty. The 6-8am window question feels underexplored in general: everything about timing assumes the day starts when the med does.

Methodology note from a fellow insufferable spreadsheet person: your week 3 electrolyte result might be contaminated — by week 3 you'd had a protein-week to compare against, and expectation effects run downhill. Randomizing the week order would've cost nothing. Says the guy who once ran a 6-week experiment with no control condition.

ADHD brains tend to “prefer” one stimulant family. You don’t know which until you try, but there are predictive patterns. Methylphenidate-based (MPH)Smoother onset More “cognitive clarity” Less emotional intensity Often better for inattentive presentations Lower risk of anxiety activation Shorter duration in many formulations Amphetamine-based (AMP)Stronger effect on motivation and drive More “get up and go” Often better for combined/hyperactive presentations Can be more activating (good or bad) Longer duration options Higher risk of appetite suppression and insomnia If anxiety is prominent then we would start with methylphenidate such as biphentin, concerta or foquest. If low motivation or initiation is the primary complaint then an amphetamine like vyvanse, or adderall XR would be initiated. If the primary presentation is inattentive then methylphenidate tends to be a better first trial. If the presentation is combined hyperactive and inattentive then amphetamine provides a stronger symptom control If there are issues with poor sleep and or poor appetite then methylphenidate would be preferred first choice. Response to past medications can also give a good clue as to what will work, for example if the patient or a first degree relative responds well to either a methylphenidate or amphetamine based medication. It is always important to remember this is a first trial, so starting low, titrate slow, assess function not feeling, tracking appetite, sleep and task performance is key.

Question since you have the data: did you notice a threshold effect or was it linear? Mine feels like a cliff at exactly 6.5hrs which seems suspiciously tidy. Wondering if that's common or if I'm pattern-matching noise.

Day 4 'music is wallpaper' — I've never seen the early flatness described that precisely. Mine lifted around day 10, same as yours. The scheduled protein shake as a calendar meeting is a genuinely good hack that I'm stealing.

Aire ouverte aussi, non divulgué aussi. Ce qui a marché sans jamais prononcer « TDAH » : j'ai demandé un « aménagement de concentration » en termes de productivité — poste face au mur, deux blocs de deux heures réservables en salle fermée, casque = ne pas déranger officialisé. Mon gestionnaire a dit oui en cinq minutes parce que j'ai apporté une solution, pas un dossier. Les RH n'ont jamais été impliquées.

Was your chart twin (both boxes tickable, disoriented by it). What my psychiatrist actually used, as far as I could tell from her questions: the timeline (my concentration issues predate every low mood by a decade), the shape of anhedonia (I never stopped WANTING to do hobbies — I couldn't START them, apparently a meaningful distinction), and what 'good periods' looked like (my good months still contained lost keys and abandoned projects). You're not a difficult chart, you're a common chart that needs someone to take a proper history.

Week 6 Strattera here, needed to read this today. The 'is this placebo for $80' phase is REAL and nobody on the stimulant side of the forum gets it. Bookmarking your week-8 description as motivation to hold on.